Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily

Viridian Therapeutics (VRDN) Technical Analysis

1,036 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Viridian Therapeutics’s (VRDN) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Viridian Therapeutics is a Sell.
Viridian Therapeutics’s (VRDN) 20-Day exponential moving average is 12.89, while Viridian Therapeutics’s (VRDN) share price is $14.69, making it a Buy.
Viridian Therapeutics’s (VRDN) 50-Day exponential moving average is 13.32, while Viridian Therapeutics’s (VRDN) share price is $14.69, making it a Buy.

Viridian Therapeutics (VRDN) Pivot Points

Nov 05, 2024, 10:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.15
12.66
13.27
13.78
14.39
14.90
15.51
Fibonacci
12.66
13.08
13.35
13.78
14.20
14.47
14.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viridian Therapeutics (VRDN) Moving Averages

Nov 05, 2024, 10:23 AM
Period
Simple
Exponential
MA5
13.23Buy
13.56Buy
MA10
12.84Buy
13.12Buy
MA20
12.71Buy
12.89Buy
MA50
13.05Buy
13.32Buy
MA100
14.96Sell
14.50Buy
MA200
16.12Sell
15.72Sell
Viridian Therapeutics’s (VRDN) 10-Day exponential moving average is 13.12, while Viridian Therapeutics’s (VRDN) share price is $14.69, making it a Buy.
Viridian Therapeutics’s (VRDN) 100-Day exponential moving average is 14.50, while Viridian Therapeutics’s (VRDN) share price is $14.69, making it a Buy.
Viridian Therapeutics’s (VRDN) stock price is $14.69 and Viridian Therapeutics’s (VRDN) 50-day simple moving average is 13.05, creating a Buy signal.
Viridian Therapeutics’s (VRDN) stock price is $14.69 and Viridian Therapeutics’s (VRDN) 100-day simple moving average is 14.96, creating a Sell signal.
Viridian Therapeutics’s (VRDN) stock price is $14.69 and Viridian Therapeutics’s (VRDN) 200-day simple moving average is 16.12, creating a Sell signal.

Viridian Therapeutics (VRDN) Technical Indicators

Nov 05, 2024, 10:23 AM
Name
Value
Implied Action
RSI (14)
67.05
Neutral
STOCH (9,6)
82.48
Sell
STOCHRSI (14)
82.48
Sell
MACD (12,26)
0.15
Sell
ADX (14)
14.91
Buy
Williams %R
-9.12
Sell
CCI (14)
273.98
Sell
ATR (14)
0.78
-
Ultimate Oscillator
64.38
Neutral
ROC
11.20
Buy
Viridian Therapeutics’s (VRDN) Relative Strength Index (RSI) is 67.05, creating a Neutral signal.
Viridian Therapeutics’s (VRDN) Trend Strength Indicator (ADX) is 14.91, creating a Buy signal.
Viridian Therapeutics’s (VRDN) Commodity Channel Index (CCI) is 273.98, creating a Sell signal.
Viridian Therapeutics’s (VRDN) Price Rate of Change (ROC) is 11.20, creating a Buy signal.

FAQ

Is VRDN a Buy, Hold, or Sell?
Based on VRDN’s technical indicators, VRDN is a Buy.
    What is VRDN’s RSI (14)?
    VRDN’s RSI (14) is 67.05, which suggests VRDN is a Neutral.
      What is VRDN’s MACD?
      VRDN’s MACD is 0.15, which suggests VRDN is a Sell.
        What is VRDN’s 5-day moving average?
        VRDN’s 5-day moving average is 13.23, which suggests VRDN is a Buy.
          What is VRDN’s 20-day moving average?
          VRDN 20-day moving average is 12.71, which suggests VRDN is a Buy.
            What is VRDN’s 50-day moving average?
            VRDN’s 50-day moving average is 13.05, which suggests VRDN is a Buy.
              What is VRDN’s 200-day moving average?
              VRDN’s 200-day moving average is 16.12, which suggests VRDN is a Sell.
                What is VRDN’s Williams % R (14)?
                VRDN’s Williams % R (14) is -9.12, which suggests VRDN is a Sell.
                  What is VRDN’s CCI (14)?
                  VRDN’s CCI (14) is 273.98, which suggests VRDN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis